#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=4 .
1-1	0-1	4	quantity	new	_	_
1-2	2-3	.	_	_	_	_

#Text=Discussion and Conclusions
2-1	4-14	Discussion	abstract	new	_	_
2-2	15-18	and	_	_	_	_
2-3	19-30	Conclusions	abstract	new	_	_

#Text=In this study , we considered the following two major factors that could influence the evolution of the f8/9 landscape phage library in mice : ( 1 ) its multidisperse characteristics as revealed in soft agar electrophoresis and ( 2 ) organ- and tumor-specific targets for phage binding interactions that can arise from organ- or tissue-specific gene expression .
3-1	31-33	In	_	_	_	_
3-2	34-38	this	abstract[4]	new[4]	coref	5-4[37_4]
3-3	39-44	study	abstract[4]	new[4]	_	_
3-4	45-46	,	_	_	_	_
3-5	47-49	we	person	acc	ana	4-1
3-6	50-60	considered	_	_	_	_
3-7	61-64	the	abstract[6]	new[6]	_	_
3-8	65-74	following	abstract[6]	new[6]	_	_
3-9	75-78	two	abstract[6]	new[6]	_	_
3-10	79-84	major	abstract[6]	new[6]	_	_
3-11	85-92	factors	abstract[6]	new[6]	_	_
3-12	93-97	that	_	_	_	_
3-13	98-103	could	_	_	_	_
3-14	104-113	influence	_	_	_	_
3-15	114-117	the	abstract[7]	new[7]	coref	15-8[0_7]
3-16	118-127	evolution	abstract[7]	new[7]	_	_
3-17	128-130	of	abstract[7]	new[7]	_	_
3-18	131-134	the	abstract[7]|abstract[10]	new[7]|new[10]	ana	3-29[0_10]
3-19	135-139	f8/9	abstract[7]|abstract[10]	new[7]|new[10]	_	_
3-20	140-149	landscape	abstract[7]|abstract|abstract[10]	new[7]|new|new[10]	coref	5-21
3-21	150-155	phage	abstract[7]|place|abstract[10]	new[7]|new|new[10]	coref	3-47
3-22	156-163	library	abstract[7]|abstract[10]	new[7]|new[10]	_	_
3-23	164-166	in	abstract[7]|abstract[10]	new[7]|new[10]	_	_
3-24	167-171	mice	abstract[7]|abstract[10]|animal	new[7]|new[10]|new	_	_
3-25	172-173	:	_	_	_	_
3-26	174-175	(	_	_	_	_
3-27	176-177	1	_	_	_	_
3-28	178-179	)	_	_	_	_
3-29	180-183	its	abstract|abstract[14]	giv|new[14]	coref|coref	17-29[184_0]|17-29[184_0]
3-30	184-197	multidisperse	abstract|abstract[14]	new|new[14]	_	_
3-31	198-213	characteristics	abstract[14]	new[14]	_	_
3-32	214-216	as	_	_	_	_
3-33	217-225	revealed	_	_	_	_
3-34	226-228	in	_	_	_	_
3-35	229-233	soft	object[16]	new[16]	_	_
3-36	234-238	agar	place|object[16]	new|new[16]	_	_
3-37	239-254	electrophoresis	object[16]	new[16]	_	_
3-38	255-258	and	object[16]	new[16]	_	_
3-39	259-260	(	object[16]	new[16]	_	_
3-40	261-262	2	object[16]	new[16]	_	_
3-41	263-264	)	object[16]	new[16]	_	_
3-42	265-271	organ-	abstract[17]	new[17]	_	_
3-43	272-275	and	abstract[17]	new[17]	_	_
3-44	276-290	tumor-specific	abstract[17]	new[17]	_	_
3-45	291-298	targets	abstract[17]	new[17]	_	_
3-46	299-302	for	abstract[17]	new[17]	_	_
3-47	303-308	phage	abstract[17]|abstract|abstract[19]	new[17]|giv|new[19]	coref|coref|coref|coref	4-17|4-32[33_19]|4-17|4-32[33_19]
3-48	309-316	binding	abstract[17]|abstract[19]	new[17]|new[19]	_	_
3-49	317-329	interactions	abstract[17]|abstract[19]	new[17]|new[19]	_	_
3-50	330-334	that	_	_	_	_
3-51	335-338	can	_	_	_	_
3-52	339-344	arise	_	_	_	_
3-53	345-349	from	_	_	_	_
3-54	350-356	organ-	abstract[21]	new[21]	coref	15-19[162_21]
3-55	357-359	or	abstract[21]	new[21]	_	_
3-56	360-375	tissue-specific	abstract[21]	new[21]	_	_
3-57	376-380	gene	abstract|abstract[21]	new|new[21]	coref	15-20
3-58	381-391	expression	abstract[21]	new[21]	_	_
3-59	392-393	.	_	_	_	_

#Text=We showed that modified p8 proteins displaying a fusion peptide along the length of the filamentous phage particle would create vastly different particles , each containing unique physicochemical features and supporting complex interactions within a defined microenvironment .
4-1	394-396	We	person	giv	ana	5-4
4-2	397-403	showed	_	_	_	_
4-3	404-408	that	_	_	_	_
4-4	409-417	modified	_	_	_	_
4-5	418-420	p8	abstract|substance[24]	new|new[24]	coref|coref	16-15[172_24]|16-15[172_24]
4-6	421-429	proteins	substance[24]	new[24]	_	_
4-7	430-440	displaying	_	_	_	_
4-8	441-442	a	object[26]	new[26]	coref	6-28[68_26]
4-9	443-449	fusion	abstract|object[26]	new|new[26]	coref	5-14
4-10	450-457	peptide	object[26]	new[26]	_	_
4-11	458-463	along	_	_	_	_
4-12	464-467	the	quantity[27]	new[27]	_	_
4-13	468-474	length	quantity[27]	new[27]	_	_
4-14	475-477	of	quantity[27]	new[27]	_	_
4-15	478-481	the	quantity[27]|object[29]	new[27]|new[29]	ana	4-25[0_29]
4-16	482-493	filamentous	quantity[27]|object[29]	new[27]|new[29]	_	_
4-17	494-499	phage	quantity[27]|place|object[29]	new[27]|giv|new[29]	coref	5-33
4-18	500-508	particle	quantity[27]|object[29]	new[27]|new[29]	_	_
4-19	509-514	would	_	_	_	_
4-20	515-521	create	_	_	_	_
4-21	522-528	vastly	object[30]	new[30]	coref	7-20[79_30]
4-22	529-538	different	object[30]	new[30]	_	_
4-23	539-548	particles	object[30]	new[30]	_	_
4-24	549-550	,	_	_	_	_
4-25	551-555	each	object	giv	coref	5-32[50_0]
4-26	556-566	containing	_	_	_	_
4-27	567-573	unique	abstract[32]	new[32]	coref	18-73[206_32]
4-28	574-589	physicochemical	abstract[32]	new[32]	_	_
4-29	590-598	features	abstract[32]	new[32]	_	_
4-30	599-602	and	_	_	_	_
4-31	603-613	supporting	_	_	_	_
4-32	614-621	complex	abstract[33]	giv[33]	coref	21-11[215_33]
4-33	622-634	interactions	abstract[33]	giv[33]	_	_
4-34	635-641	within	abstract[33]	giv[33]	_	_
4-35	642-643	a	abstract[33]|abstract[34]	giv[33]|new[34]	coref	7-11[75_34]
4-36	644-651	defined	abstract[33]|abstract[34]	giv[33]|new[34]	_	_
4-37	652-668	microenvironment	abstract[33]|abstract[34]	giv[33]|new[34]	_	_
4-38	669-670	.	_	_	_	_

#Text=As reflected in our in vitro migration study , the presence of random fusion peptides with charged amino acids in landscape phages results in significant changes in the ionization state of the phage particle leading to differences in surface charge and their subsequent ability to migrate through an agarose gel , demonstrated previously with isolated clones .
5-1	671-673	As	_	_	_	_
5-2	674-683	reflected	_	_	_	_
5-3	684-686	in	_	_	_	_
5-4	687-690	our	person|abstract[37]	giv|giv[37]	coref|ana|coref|ana	8-2[87_37]|9-20|8-2[87_37]|9-20
5-5	691-693	in	abstract[37]	giv[37]	_	_
5-6	694-699	vitro	abstract[37]	giv[37]	_	_
5-7	700-709	migration	abstract|abstract[37]	new|giv[37]	_	_
5-8	710-715	study	abstract[37]	giv[37]	_	_
5-9	716-717	,	_	_	_	_
5-10	718-721	the	abstract[38]	new[38]	_	_
5-11	722-730	presence	abstract[38]	new[38]	_	_
5-12	731-733	of	abstract[38]	new[38]	_	_
5-13	734-740	random	abstract[38]|substance[40]	new[38]|new[40]	_	_
5-14	741-747	fusion	abstract[38]|abstract|substance[40]	new[38]|giv|new[40]	coref	6-30
5-15	748-756	peptides	abstract[38]|substance[40]	new[38]|new[40]	_	_
5-16	757-761	with	abstract[38]|substance[40]	new[38]|new[40]	_	_
5-17	762-769	charged	abstract[38]|substance[40]|substance[42]	new[38]|new[40]|new[42]	_	_
5-18	770-775	amino	abstract[38]|substance[40]|object|substance[42]	new[38]|new[40]|new|new[42]	_	_
5-19	776-781	acids	abstract[38]|substance[40]|substance[42]	new[38]|new[40]|new[42]	_	_
5-20	782-784	in	abstract[38]|substance[40]|substance[42]	new[38]|new[40]|new[42]	_	_
5-21	785-794	landscape	abstract[38]|substance[40]|substance[42]|abstract|abstract[45]	new[38]|new[40]|new[42]|giv|new[45]	coref|coref	6-7|6-7
5-22	795-801	phages	abstract[38]|substance[40]|substance[42]|object|abstract[45]	new[38]|new[40]|new[42]|new|new[45]	coref	6-7[61_0]
5-23	802-809	results	abstract[38]|substance[40]|substance[42]|abstract[45]	new[38]|new[40]|new[42]|new[45]	_	_
5-24	810-812	in	abstract[38]|substance[40]|substance[42]|abstract[45]	new[38]|new[40]|new[42]|new[45]	_	_
5-25	813-824	significant	abstract[38]|substance[40]|substance[42]|abstract[45]|abstract[46]	new[38]|new[40]|new[42]|new[45]|new[46]	coref	7-6[72_46]
5-26	825-832	changes	abstract[38]|substance[40]|substance[42]|abstract[45]|abstract[46]	new[38]|new[40]|new[42]|new[45]|new[46]	_	_
5-27	833-835	in	abstract[38]|substance[40]|substance[42]|abstract[45]|abstract[46]	new[38]|new[40]|new[42]|new[45]|new[46]	_	_
5-28	836-839	the	abstract[38]|substance[40]|substance[42]|abstract[45]|abstract[46]|abstract[48]	new[38]|new[40]|new[42]|new[45]|new[46]|new[48]	_	_
5-29	840-850	ionization	abstract[38]|substance[40]|substance[42]|abstract[45]|abstract[46]|abstract|abstract[48]	new[38]|new[40]|new[42]|new[45]|new[46]|new|new[48]	_	_
5-30	851-856	state	abstract[38]|substance[40]|substance[42]|abstract[45]|abstract[46]|abstract[48]	new[38]|new[40]|new[42]|new[45]|new[46]|new[48]	_	_
5-31	857-859	of	abstract[38]|substance[40]|substance[42]|abstract[45]|abstract[46]|abstract[48]	new[38]|new[40]|new[42]|new[45]|new[46]|new[48]	_	_
5-32	860-863	the	abstract[38]|substance[40]|substance[42]|abstract[45]|abstract[46]|abstract[48]|object[50]	new[38]|new[40]|new[42]|new[45]|new[46]|new[48]|giv[50]	coref	6-39[70_50]
5-33	864-869	phage	abstract[38]|substance[40]|substance[42]|abstract[45]|abstract[46]|abstract[48]|place|object[50]	new[38]|new[40]|new[42]|new[45]|new[46]|new[48]|giv|giv[50]	coref	7-21
5-34	870-878	particle	abstract[38]|substance[40]|substance[42]|abstract[45]|abstract[46]|abstract[48]|object[50]	new[38]|new[40]|new[42]|new[45]|new[46]|new[48]|giv[50]	_	_
5-35	879-886	leading	_	_	_	_
5-36	887-889	to	_	_	_	_
5-37	890-901	differences	abstract[51]	new[51]	_	_
5-38	902-904	in	abstract[51]	new[51]	_	_
5-39	905-912	surface	abstract[51]|place|abstract[53]|abstract[54]	new[51]|new|new[53]|new[54]	coref|coref|coref|coref|coref|coref	7-17|7-16[77_53]|7-17|7-16[77_53]|7-17|7-16[77_53]
5-40	913-919	charge	abstract[51]|abstract[53]|abstract[54]	new[51]|new[53]|new[54]	_	_
5-41	920-923	and	abstract[51]|abstract[54]	new[51]|new[54]	_	_
5-42	924-929	their	abstract[51]|abstract[54]|abstract[55]	new[51]|new[54]|new[55]	coref	6-25[66_55]
5-43	930-940	subsequent	abstract[51]|abstract[54]|abstract[55]	new[51]|new[54]|new[55]	_	_
5-44	941-948	ability	abstract[51]|abstract[54]|abstract[55]	new[51]|new[54]|new[55]	_	_
5-45	949-951	to	_	_	_	_
5-46	952-959	migrate	_	_	_	_
5-47	960-967	through	_	_	_	_
5-48	968-970	an	object[57]	new[57]	_	_
5-49	971-978	agarose	abstract|object[57]	new|new[57]	_	_
5-50	979-982	gel	object[57]	new[57]	_	_
5-51	983-984	,	_	_	_	_
5-52	985-997	demonstrated	_	_	_	_
5-53	998-1008	previously	_	_	_	_
5-54	1009-1013	with	_	_	_	_
5-55	1014-1022	isolated	object[58]	new[58]	_	_
5-56	1023-1029	clones	object[58]	new[58]	_	_
5-57	1030-1031	.	_	_	_	_

#Text=This unique , emergent feature of landscape phages cannot be translated to p3-type libraries as the occurrence of p3 in only five copies limits the ability of a displayed fusion peptide to significantly change the physicochemical properties of the entire particle .
6-1	1032-1036	This	abstract[59]	new[59]	_	_
6-2	1037-1043	unique	abstract[59]	new[59]	_	_
6-3	1044-1045	,	abstract[59]	new[59]	_	_
6-4	1046-1054	emergent	abstract[59]	new[59]	_	_
6-5	1055-1062	feature	abstract[59]	new[59]	_	_
6-6	1063-1065	of	abstract[59]	new[59]	_	_
6-7	1066-1075	landscape	abstract[59]|abstract|object[61]	new[59]|giv|giv[61]	coref|coref|coref|coref	9-3|15-11[159_61]|9-3|15-11[159_61]
6-8	1076-1082	phages	abstract[59]|object[61]	new[59]|giv[61]	_	_
6-9	1083-1089	cannot	_	_	_	_
6-10	1090-1092	be	_	_	_	_
6-11	1093-1103	translated	_	_	_	_
6-12	1104-1106	to	_	_	_	_
6-13	1107-1114	p3-type	place[62]	new[62]	coref	9-3[102_62]
6-14	1115-1124	libraries	place[62]	new[62]	_	_
6-15	1125-1127	as	place[62]	new[62]	_	_
6-16	1128-1131	the	place[62]	new[62]	_	_
6-17	1132-1142	occurrence	place[62]	new[62]	_	_
6-18	1143-1145	of	place[62]	new[62]	_	_
6-19	1146-1148	p3	place[62]|substance	new[62]|new	_	_
6-20	1149-1151	in	_	_	_	_
6-21	1152-1156	only	quantity[64]|abstract[65]	new[64]|new[65]	_	_
6-22	1157-1161	five	quantity[64]|abstract[65]	new[64]|new[65]	_	_
6-23	1162-1168	copies	quantity[64]|abstract[65]	new[64]|new[65]	_	_
6-24	1169-1175	limits	abstract[65]	new[65]	_	_
6-25	1176-1179	the	abstract[65]|abstract[66]	new[65]|giv[66]	ana	7-1[0_66]
6-26	1180-1187	ability	abstract[65]|abstract[66]	new[65]|giv[66]	_	_
6-27	1188-1190	of	abstract[65]|abstract[66]	new[65]|giv[66]	_	_
6-28	1191-1192	a	abstract[65]|abstract[66]|object[68]	new[65]|giv[66]|giv[68]	coref	9-7[0_68]
6-29	1193-1202	displayed	abstract[65]|abstract[66]|object[68]	new[65]|giv[66]|giv[68]	_	_
6-30	1203-1209	fusion	abstract[65]|abstract[66]|abstract|object[68]	new[65]|giv[66]|giv|giv[68]	_	_
6-31	1210-1217	peptide	abstract[65]|abstract[66]|object[68]	new[65]|giv[66]|giv[68]	_	_
6-32	1218-1220	to	_	_	_	_
6-33	1221-1234	significantly	_	_	_	_
6-34	1235-1241	change	_	_	_	_
6-35	1242-1245	the	abstract[69]	new[69]	_	_
6-36	1246-1261	physicochemical	abstract[69]	new[69]	_	_
6-37	1262-1272	properties	abstract[69]	new[69]	_	_
6-38	1273-1275	of	abstract[69]	new[69]	_	_
6-39	1276-1279	the	abstract[69]|object[70]	new[69]|giv[70]	coref	8-31[0_70]
6-40	1280-1286	entire	abstract[69]|object[70]	new[69]|giv[70]	_	_
6-41	1287-1295	particle	abstract[69]|object[70]	new[69]|giv[70]	_	_
6-42	1296-1297	.	_	_	_	_

#Text=It can be envisioned that local changes in pH within a tissue microenvironment may modify the surface charge of landscape phage particles , exposing a previously hidden binding epitope or also hiding a previously accessible binding epitope allowing enhanced penetration or retention within a particular microenvironment .
7-1	1298-1300	It	abstract	giv	_	_
7-2	1301-1304	can	_	_	_	_
7-3	1305-1307	be	_	_	_	_
7-4	1308-1318	envisioned	_	_	_	_
7-5	1319-1323	that	_	_	_	_
7-6	1324-1329	local	abstract[72]	giv[72]	_	_
7-7	1330-1337	changes	abstract[72]	giv[72]	_	_
7-8	1338-1340	in	abstract[72]	giv[72]	_	_
7-9	1341-1343	pH	abstract[72]|abstract[73]	giv[72]|new[73]	_	_
7-10	1344-1350	within	abstract[72]|abstract[73]	giv[72]|new[73]	_	_
7-11	1351-1352	a	abstract[72]|abstract[73]|abstract[75]	giv[72]|new[73]|giv[75]	coref	7-44[86_75]
7-12	1353-1359	tissue	abstract[72]|abstract[73]|object|abstract[75]	giv[72]|new[73]|new|giv[75]	coref	10-10
7-13	1360-1376	microenvironment	abstract[72]|abstract[73]|abstract[75]	giv[72]|new[73]|giv[75]	_	_
7-14	1377-1380	may	_	_	_	_
7-15	1381-1387	modify	_	_	_	_
7-16	1388-1391	the	abstract[77]	giv[77]	coref	8-19[92_77]
7-17	1392-1399	surface	place|abstract[77]	giv|giv[77]	coref	8-22
7-18	1400-1406	charge	abstract[77]	giv[77]	_	_
7-19	1407-1409	of	abstract[77]	giv[77]	_	_
7-20	1410-1419	landscape	abstract[77]|object[79]	giv[77]|giv[79]	coref	9-25[111_79]
7-21	1420-1425	phage	abstract[77]|place|object[79]	giv[77]|giv|giv[79]	coref	9-4
7-22	1426-1435	particles	abstract[77]|object[79]	giv[77]|giv[79]	_	_
7-23	1436-1437	,	_	_	_	_
7-24	1438-1446	exposing	_	_	_	_
7-25	1447-1448	a	object[81]	new[81]	coref	7-33[83_81]
7-26	1449-1459	previously	object[81]	new[81]	_	_
7-27	1460-1466	hidden	object[81]	new[81]	_	_
7-28	1467-1474	binding	object|object[81]	new|new[81]	coref	7-36
7-29	1475-1482	epitope	object[81]	new[81]	_	_
7-30	1483-1485	or	_	_	_	_
7-31	1486-1490	also	_	_	_	_
7-32	1491-1497	hiding	_	_	_	_
7-33	1498-1499	a	object[83]	giv[83]	_	_
7-34	1500-1510	previously	object[83]	giv[83]	_	_
7-35	1511-1521	accessible	object[83]	giv[83]	_	_
7-36	1522-1529	binding	object|object[83]	giv|giv[83]	_	_
7-37	1530-1537	epitope	object[83]	giv[83]	_	_
7-38	1538-1546	allowing	_	_	_	_
7-39	1547-1555	enhanced	abstract[84]	new[84]	_	_
7-40	1556-1567	penetration	abstract[84]	new[84]	_	_
7-41	1568-1570	or	_	_	_	_
7-42	1571-1580	retention	abstract[85]	new[85]	_	_
7-43	1581-1587	within	abstract[85]	new[85]	_	_
7-44	1588-1589	a	abstract[85]|abstract[86]	new[85]|giv[86]	ana	8-12[0_86]
7-45	1590-1600	particular	abstract[85]|abstract[86]	new[85]|giv[86]	_	_
7-46	1601-1617	microenvironment	abstract[85]|abstract[86]	new[85]|giv[86]	_	_
7-47	1618-1619	.	_	_	_	_

#Text=Following an extensive meta-analysis study of nanoparticle biocompatibility in vivo , it was concluded that functional nanocarriers had a slightly negative surface charge , moderate to high solubility , and particle sizes in the range of ~100 – 200 nm in diameter .
8-1	1620-1629	Following	_	_	_	_
8-2	1630-1632	an	abstract[87]	giv[87]	coref	10-2[123_87]
8-3	1633-1642	extensive	abstract[87]	giv[87]	_	_
8-4	1643-1656	meta-analysis	abstract[87]	giv[87]	_	_
8-5	1657-1662	study	abstract[87]	giv[87]	_	_
8-6	1663-1665	of	abstract[87]	giv[87]	_	_
8-7	1666-1678	nanoparticle	abstract[87]|substance[88]	giv[87]|new[88]	_	_
8-8	1679-1695	biocompatibility	abstract[87]|substance[88]	giv[87]|new[88]	_	_
8-9	1696-1698	in	abstract[87]|substance[88]	giv[87]|new[88]	_	_
8-10	1699-1703	vivo	abstract[87]|substance[88]	giv[87]|new[88]	_	_
8-11	1704-1705	,	_	_	_	_
8-12	1706-1708	it	abstract	giv	coref	9-43[117_0]
8-13	1709-1712	was	_	_	_	_
8-14	1713-1722	concluded	_	_	_	_
8-15	1723-1727	that	_	_	_	_
8-16	1728-1738	functional	object[90]	new[90]	_	_
8-17	1739-1751	nanocarriers	object[90]	new[90]	_	_
8-18	1752-1755	had	_	_	_	_
8-19	1756-1757	a	abstract[92]	giv[92]	_	_
8-20	1758-1766	slightly	abstract[92]	giv[92]	_	_
8-21	1767-1775	negative	abstract[92]	giv[92]	_	_
8-22	1776-1783	surface	place|abstract[92]	giv|giv[92]	coref	9-14
8-23	1784-1790	charge	abstract[92]	giv[92]	_	_
8-24	1791-1792	,	_	_	_	_
8-25	1793-1801	moderate	_	_	_	_
8-26	1802-1804	to	_	_	_	_
8-27	1805-1809	high	substance[93]	new[93]	_	_
8-28	1810-1820	solubility	substance[93]	new[93]	_	_
8-29	1821-1822	,	_	_	_	_
8-30	1823-1826	and	_	_	_	_
8-31	1827-1835	particle	object|quantity[95]	giv|new[95]	coref|coref	9-52|9-52
8-32	1836-1841	sizes	quantity[95]	new[95]	_	_
8-33	1842-1844	in	quantity[95]	new[95]	_	_
8-34	1845-1848	the	quantity[95]|abstract[96]	new[95]|new[96]	_	_
8-35	1849-1854	range	quantity[95]|abstract[96]	new[95]|new[96]	_	_
8-36	1855-1857	of	quantity[95]|abstract[96]	new[95]|new[96]	_	_
8-37	1858-1862	~100	quantity[95]|abstract[96]|abstract[97]	new[95]|new[96]|new[97]	_	_
8-38	1863-1864	–	quantity[95]|abstract[96]|abstract[97]	new[95]|new[96]|new[97]	_	_
8-39	1865-1868	200	quantity[95]|abstract[96]|abstract[97]|quantity[98]	new[95]|new[96]|new[97]|new[98]	_	_
8-40	1869-1871	nm	quantity[95]|abstract[96]|abstract[97]|quantity[98]	new[95]|new[96]|new[97]|new[98]	_	_
8-41	1872-1874	in	quantity[95]|abstract[96]|abstract[97]|quantity[98]	new[95]|new[96]|new[97]|new[98]	_	_
8-42	1875-1883	diameter	quantity[95]|abstract[96]|abstract[97]|quantity[98]|abstract	new[95]|new[96]|new[97]|new[98]|new	_	_
8-43	1884-1885	.	_	_	_	_

#Text=Given that landscape phage libraries display peptide fusions that can dramatically alter the surface profile of the phage , we hypothesized that libraries of phage particles represent ideal nanoparticle systems to test the effects of a displayed peptide on tissue-selective accumulation within the local microenvironment while maintaining other critical parameters like particle size and shape .
9-1	1886-1891	Given	_	_	_	_
9-2	1892-1896	that	_	_	_	_
9-3	1897-1906	landscape	abstract|place[102]	giv|giv[102]	coref|coref|coref|coref	9-23[109_102]|15-11|9-23[109_102]|15-11
9-4	1907-1912	phage	abstract|place[102]	giv|giv[102]	coref	9-17[107_0]
9-5	1913-1922	libraries	place[102]	giv[102]	_	_
9-6	1923-1930	display	_	_	_	_
9-7	1931-1938	peptide	object|abstract[104]	giv|new[104]	coref|coref	9-36[115_0]|9-36[115_0]
9-8	1939-1946	fusions	abstract[104]	new[104]	_	_
9-9	1947-1951	that	_	_	_	_
9-10	1952-1955	can	_	_	_	_
9-11	1956-1968	dramatically	_	_	_	_
9-12	1969-1974	alter	_	_	_	_
9-13	1975-1978	the	abstract[106]	new[106]	_	_
9-14	1979-1986	surface	place|abstract[106]	giv|new[106]	_	_
9-15	1987-1994	profile	abstract[106]	new[106]	_	_
9-16	1995-1997	of	abstract[106]	new[106]	_	_
9-17	1998-2001	the	abstract[106]|place[107]	new[106]|giv[107]	coref	9-25[0_107]
9-18	2002-2007	phage	abstract[106]|place[107]	new[106]|giv[107]	_	_
9-19	2008-2009	,	_	_	_	_
9-20	2010-2012	we	person	giv	ana	10-2
9-21	2013-2025	hypothesized	_	_	_	_
9-22	2026-2030	that	_	_	_	_
9-23	2031-2040	libraries	place[109]	giv[109]	coref	10-16[128_109]
9-24	2041-2043	of	place[109]	giv[109]	_	_
9-25	2044-2049	phage	place[109]|place|object[111]	giv[109]|giv|giv[111]	coref|coref	17-32|17-32
9-26	2050-2059	particles	place[109]|object[111]	giv[109]|giv[111]	_	_
9-27	2060-2069	represent	_	_	_	_
9-28	2070-2075	ideal	abstract[113]	new[113]	_	_
9-29	2076-2088	nanoparticle	quantity|abstract[113]	new|new[113]	_	_
9-30	2089-2096	systems	abstract[113]	new[113]	_	_
9-31	2097-2099	to	_	_	_	_
9-32	2100-2104	test	_	_	_	_
9-33	2105-2108	the	abstract[114]	new[114]	_	_
9-34	2109-2116	effects	abstract[114]	new[114]	_	_
9-35	2117-2119	of	abstract[114]	new[114]	_	_
9-36	2120-2121	a	abstract[114]|object[115]	new[114]|giv[115]	coref	14-17[0_115]
9-37	2122-2131	displayed	abstract[114]|object[115]	new[114]|giv[115]	_	_
9-38	2132-2139	peptide	abstract[114]|object[115]	new[114]|giv[115]	_	_
9-39	2140-2142	on	abstract[114]|object[115]	new[114]|giv[115]	_	_
9-40	2143-2159	tissue-selective	abstract[114]|object[115]|abstract[116]	new[114]|giv[115]|new[116]	coref	10-10[127_116]
9-41	2160-2172	accumulation	abstract[114]|object[115]|abstract[116]	new[114]|giv[115]|new[116]	_	_
9-42	2173-2179	within	abstract[114]|object[115]|abstract[116]	new[114]|giv[115]|new[116]	_	_
9-43	2180-2183	the	abstract[114]|object[115]|abstract[116]|abstract[117]	new[114]|giv[115]|new[116]|giv[117]	coref	18-77[207_117]
9-44	2184-2189	local	abstract[114]|object[115]|abstract[116]|abstract[117]	new[114]|giv[115]|new[116]|giv[117]	_	_
9-45	2190-2206	microenvironment	abstract[114]|object[115]|abstract[116]|abstract[117]	new[114]|giv[115]|new[116]|giv[117]	_	_
9-46	2207-2212	while	_	_	_	_
9-47	2213-2224	maintaining	_	_	_	_
9-48	2225-2230	other	abstract[118]	new[118]	_	_
9-49	2231-2239	critical	abstract[118]	new[118]	_	_
9-50	2240-2250	parameters	abstract[118]	new[118]	_	_
9-51	2251-2255	like	abstract[118]	new[118]	_	_
9-52	2256-2264	particle	abstract[118]|object|abstract[120]	new[118]|giv|new[120]	_	_
9-53	2265-2269	size	abstract[118]|abstract[120]	new[118]|new[120]	_	_
9-54	2270-2273	and	abstract[118]	new[118]	_	_
9-55	2274-2279	shape	abstract[118]|abstract	new[118]|new	_	_
9-56	2280-2281	.	_	_	_	_

#Text=In our study , we observed similar trends of tissue accumulation as reported previously for p3-type libraries .
10-1	2282-2284	In	_	_	_	_
10-2	2285-2288	our	person|abstract[123]	giv|giv[123]	ana|ana	10-5|10-5
10-3	2289-2294	study	abstract[123]	giv[123]	_	_
10-4	2295-2296	,	_	_	_	_
10-5	2297-2299	we	person	giv	ana	12-1
10-6	2300-2308	observed	_	_	_	_
10-7	2309-2316	similar	abstract[125]	new[125]	_	_
10-8	2317-2323	trends	abstract[125]	new[125]	_	_
10-9	2324-2326	of	abstract[125]	new[125]	_	_
10-10	2327-2333	tissue	abstract[125]|object|abstract[127]	new[125]|giv|giv[127]	coref|coref|coref|coref	11-6[131_0]|14-25[152_127]|11-6[131_0]|14-25[152_127]
10-11	2334-2346	accumulation	abstract[125]|abstract[127]	new[125]|giv[127]	_	_
10-12	2347-2349	as	_	_	_	_
10-13	2350-2358	reported	_	_	_	_
10-14	2359-2369	previously	_	_	_	_
10-15	2370-2373	for	_	_	_	_
10-16	2374-2381	p3-type	place[128]	giv[128]	coref	17-25[181_128]
10-17	2382-2391	libraries	place[128]	giv[128]	_	_
10-18	2392-2393	.	_	_	_	_

#Text=Analysis of 3-mer frequency in each tissue revealed that a significant portion of motifs were shared across all tissues , leading to nonspecific uptake and clearance or had very low occurrences .
11-1	2394-2402	Analysis	abstract[129]	new[129]	_	_
11-2	2403-2405	of	abstract[129]	new[129]	_	_
11-3	2406-2411	3-mer	abstract[129]|abstract[130]	new[129]|new[130]	_	_
11-4	2412-2421	frequency	abstract[129]|abstract[130]	new[129]|new[130]	_	_
11-5	2422-2424	in	abstract[129]|abstract[130]	new[129]|new[130]	_	_
11-6	2425-2429	each	abstract[129]|abstract[130]|object[131]	new[129]|new[130]|giv[131]	coref	14-25[0_131]
11-7	2430-2436	tissue	abstract[129]|abstract[130]|object[131]	new[129]|new[130]|giv[131]	_	_
11-8	2437-2445	revealed	_	_	_	_
11-9	2446-2450	that	_	_	_	_
11-10	2451-2452	a	abstract[132]	new[132]	_	_
11-11	2453-2464	significant	abstract[132]	new[132]	_	_
11-12	2465-2472	portion	abstract[132]	new[132]	_	_
11-13	2473-2475	of	abstract[132]	new[132]	_	_
11-14	2476-2482	motifs	abstract[132]|abstract	new[132]|new	coref	12-9
11-15	2483-2487	were	_	_	_	_
11-16	2488-2494	shared	_	_	_	_
11-17	2495-2501	across	_	_	_	_
11-18	2502-2505	all	abstract[134]	new[134]	coref	18-24[193_134]
11-19	2506-2513	tissues	abstract[134]	new[134]	_	_
11-20	2514-2515	,	_	_	_	_
11-21	2516-2523	leading	_	_	_	_
11-22	2524-2526	to	_	_	_	_
11-23	2527-2538	nonspecific	abstract[135]	new[135]	_	_
11-24	2539-2545	uptake	abstract[135]	new[135]	_	_
11-25	2546-2549	and	_	_	_	_
11-26	2550-2559	clearance	abstract	new	_	_
11-27	2560-2562	or	_	_	_	_
11-28	2563-2566	had	_	_	_	_
11-29	2567-2571	very	abstract[137]	new[137]	_	_
11-30	2572-2575	low	abstract[137]	new[137]	_	_
11-31	2576-2587	occurrences	abstract[137]	new[137]	_	_
11-32	2588-2589	.	_	_	_	_

#Text=We were able to identify several families of motifs that were enriched in a tissue-selective manner .
12-1	2590-2592	We	person	giv	ana	14-3
12-2	2593-2597	were	_	_	_	_
12-3	2598-2602	able	_	_	_	_
12-4	2603-2605	to	_	_	_	_
12-5	2606-2614	identify	_	_	_	_
12-6	2615-2622	several	abstract[139]	new[139]	_	_
12-7	2623-2631	families	abstract[139]	new[139]	_	_
12-8	2632-2634	of	abstract[139]	new[139]	_	_
12-9	2635-2641	motifs	abstract[139]|abstract	new[139]|giv	coref	13-3[143_0]
12-10	2642-2646	that	_	_	_	_
12-11	2647-2651	were	_	_	_	_
12-12	2652-2660	enriched	_	_	_	_
12-13	2661-2663	in	_	_	_	_
12-14	2664-2665	a	abstract[141]	new[141]	ana	13-1[142_141]
12-15	2666-2682	tissue-selective	abstract[141]	new[141]	_	_
12-16	2683-2689	manner	abstract[141]	new[141]	_	_
12-17	2690-2691	.	_	_	_	_

#Text=Some of the identified motifs corresponded with previously identified tissue-selective motifs .
13-1	2692-2696	Some	abstract[142]	giv[142]	_	_
13-2	2697-2699	of	abstract[142]	giv[142]	_	_
13-3	2700-2703	the	abstract[142]|abstract[143]	giv[142]|giv[143]	coref	13-8[144_143]
13-4	2704-2714	identified	abstract[142]|abstract[143]	giv[142]|giv[143]	_	_
13-5	2715-2721	motifs	abstract[142]|abstract[143]	giv[142]|giv[143]	_	_
13-6	2722-2734	corresponded	_	_	_	_
13-7	2735-2739	with	_	_	_	_
13-8	2740-2750	previously	abstract[144]	giv[144]	coref	14-5[146_144]
13-9	2751-2761	identified	abstract[144]	giv[144]	_	_
13-10	2762-2778	tissue-selective	abstract[144]	giv[144]	_	_
13-11	2779-2785	motifs	abstract[144]	giv[144]	_	_
13-12	2786-2787	.	_	_	_	_

#Text=However , we identified many motifs that were not reported , suggesting that the type of peptide display will have a significant effect on tissue accumulation or pharmacokinetics .
14-1	2788-2795	However	_	_	_	_
14-2	2796-2797	,	_	_	_	_
14-3	2798-2800	we	person	giv	ana	15-5
14-4	2801-2811	identified	_	_	_	_
14-5	2812-2816	many	abstract[146]	giv[146]	coref	18-15[191_146]
14-6	2817-2823	motifs	abstract[146]	giv[146]	_	_
14-7	2824-2828	that	_	_	_	_
14-8	2829-2833	were	_	_	_	_
14-9	2834-2837	not	_	_	_	_
14-10	2838-2846	reported	_	_	_	_
14-11	2847-2848	,	_	_	_	_
14-12	2849-2859	suggesting	_	_	_	_
14-13	2860-2864	that	_	_	_	_
14-14	2865-2868	the	event[147]	new[147]	_	_
14-15	2869-2873	type	event[147]	new[147]	_	_
14-16	2874-2876	of	event[147]	new[147]	_	_
14-17	2877-2884	peptide	event[147]|object|object[149]	new[147]|giv|new[149]	coref|coref	17-25|17-25
14-18	2885-2892	display	event[147]|object[149]	new[147]|new[149]	_	_
14-19	2893-2897	will	_	_	_	_
14-20	2898-2902	have	_	_	_	_
14-21	2903-2904	a	abstract[150]	new[150]	_	_
14-22	2905-2916	significant	abstract[150]	new[150]	_	_
14-23	2917-2923	effect	abstract[150]	new[150]	_	_
14-24	2924-2926	on	abstract[150]	new[150]	_	_
14-25	2927-2933	tissue	abstract[150]|object|abstract[152]	new[150]|giv|giv[152]	coref|coref|coref|coref	15-29|27-33[260_152]|15-29|27-33[260_152]
14-26	2934-2946	accumulation	abstract[150]|abstract[152]	new[150]|giv[152]	_	_
14-27	2947-2949	or	abstract[150]	new[150]	_	_
14-28	2950-2966	pharmacokinetics	abstract[150]|abstract	new[150]|new	_	_
14-29	2967-2968	.	_	_	_	_

#Text=The underlying hypothesis in our in vivo evolution study of landscape phages is based on the assumption that tissue-specific gene expression provides a context-dependent pathway for development of tissue specificity .
15-1	2969-2972	The	abstract[154]	new[154]	coref	18-4[186_154]
15-2	2973-2983	underlying	abstract[154]	new[154]	_	_
15-3	2984-2994	hypothesis	abstract[154]	new[154]	_	_
15-4	2995-2997	in	abstract[154]	new[154]	_	_
15-5	2998-3001	our	abstract[154]|person|abstract[157]	new[154]|giv|new[157]	ana|ana	18-7|18-7
15-6	3002-3004	in	abstract[154]|abstract[157]	new[154]|new[157]	_	_
15-7	3005-3009	vivo	abstract[154]|abstract[157]	new[154]|new[157]	_	_
15-8	3010-3019	evolution	abstract[154]|abstract|abstract[157]	new[154]|giv|new[157]	_	_
15-9	3020-3025	study	abstract[154]|abstract[157]	new[154]|new[157]	_	_
15-10	3026-3028	of	abstract[154]|abstract[157]	new[154]|new[157]	_	_
15-11	3029-3038	landscape	abstract[154]|abstract[157]|abstract|abstract[159]	new[154]|new[157]|giv|giv[159]	coref|coref|coref|coref	17-31|27-36[0_159]|17-31|27-36[0_159]
15-12	3039-3045	phages	abstract[154]|abstract[157]|abstract[159]	new[154]|new[157]|giv[159]	_	_
15-13	3046-3048	is	_	_	_	_
15-14	3049-3054	based	_	_	_	_
15-15	3055-3057	on	_	_	_	_
15-16	3058-3061	the	abstract[160]	new[160]	_	_
15-17	3062-3072	assumption	abstract[160]	new[160]	_	_
15-18	3073-3077	that	abstract[160]	new[160]	_	_
15-19	3078-3093	tissue-specific	abstract[160]|abstract[162]	new[160]|giv[162]	coref	16-3[168_162]
15-20	3094-3098	gene	abstract[160]|abstract|abstract[162]	new[160]|giv|giv[162]	coref	16-3
15-21	3099-3109	expression	abstract[160]|abstract[162]	new[160]|giv[162]	_	_
15-22	3110-3118	provides	abstract[160]	new[160]	_	_
15-23	3119-3120	a	abstract[160]|abstract[163]	new[160]|new[163]	_	_
15-24	3121-3138	context-dependent	abstract[160]|abstract[163]	new[160]|new[163]	_	_
15-25	3139-3146	pathway	abstract[160]|abstract[163]	new[160]|new[163]	_	_
15-26	3147-3150	for	abstract[160]|abstract[163]	new[160]|new[163]	_	_
15-27	3151-3162	development	abstract[160]|abstract[163]|event[164]	new[160]|new[163]|new[164]	_	_
15-28	3163-3165	of	abstract[160]|abstract[163]|event[164]	new[160]|new[163]|new[164]	_	_
15-29	3166-3172	tissue	abstract[160]|abstract[163]|event[164]|object|abstract[166]	new[160]|new[163]|new[164]|giv|new[166]	coref|coref	19-16|19-16
15-30	3173-3184	specificity	abstract[160]|abstract[163]|event[164]|abstract[166]	new[160]|new[163]|new[164]|new[166]	_	_
15-31	3185-3186	.	_	_	_	_

#Text=These tissue-specific gene expression profiles provide transcriptional and translational control for tissue-specific synthesis of corresponding proteins and their underlying protein-domain networks .
16-1	3187-3192	These	object[169]	new[169]	ana	16-18[0_169]
16-2	3193-3208	tissue-specific	object[169]	new[169]	_	_
16-3	3209-3213	gene	abstract|abstract[168]|object[169]	giv|giv[168]|new[169]	coref|coref|coref|coref	18-65|18-66[0_168]|18-65|18-66[0_168]
16-4	3214-3224	expression	abstract[168]|object[169]	giv[168]|new[169]	_	_
16-5	3225-3233	profiles	object[169]	new[169]	_	_
16-6	3234-3241	provide	_	_	_	_
16-7	3242-3257	transcriptional	abstract[170]	new[170]	_	_
16-8	3258-3261	and	abstract[170]	new[170]	_	_
16-9	3262-3275	translational	abstract[170]	new[170]	_	_
16-10	3276-3283	control	abstract[170]	new[170]	_	_
16-11	3284-3287	for	abstract[170]	new[170]	_	_
16-12	3288-3303	tissue-specific	abstract[170]|abstract[171]	new[170]|new[171]	ana	17-1[0_171]
16-13	3304-3313	synthesis	abstract[170]|abstract[171]	new[170]|new[171]	_	_
16-14	3314-3316	of	abstract[170]|abstract[171]	new[170]|new[171]	_	_
16-15	3317-3330	corresponding	abstract[170]|abstract[171]|substance[172]	new[170]|new[171]|giv[172]	_	_
16-16	3331-3339	proteins	abstract[170]|abstract[171]|substance[172]	new[170]|new[171]|giv[172]	_	_
16-17	3340-3343	and	abstract[170]|abstract[171]|substance[172]	new[170]|new[171]|giv[172]	_	_
16-18	3344-3349	their	abstract[170]|abstract[171]|substance[172]|object|abstract[174]	new[170]|new[171]|giv[172]|giv|new[174]	coref|coref|coref|coref	17-7[177_174]|18-64[204_0]|17-7[177_174]|18-64[204_0]
16-19	3350-3360	underlying	abstract[170]|abstract[171]|substance[172]|abstract[174]	new[170]|new[171]|giv[172]|new[174]	_	_
16-20	3361-3375	protein-domain	abstract[170]|abstract[171]|substance[172]|abstract[174]	new[170]|new[171]|giv[172]|new[174]	_	_
16-21	3376-3384	networks	abstract[170]|abstract[171]|substance[172]|abstract[174]	new[170]|new[171]|giv[172]|new[174]	_	_
16-22	3385-3386	.	_	_	_	_

#Text=It was suggested that components of these protein-domain networks could be identified through in vitro or in vivo targeted evolution of EBU/SLiM-harboring phage displayed peptide libraries such as the multivalent landscape phage library used in this project .
17-1	3387-3389	It	abstract	giv	_	_
17-2	3390-3393	was	_	_	_	_
17-3	3394-3403	suggested	_	_	_	_
17-4	3404-3408	that	_	_	_	_
17-5	3409-3419	components	abstract[176]	new[176]	_	_
17-6	3420-3422	of	abstract[176]	new[176]	_	_
17-7	3423-3428	these	abstract[176]|abstract[177]	new[176]|giv[177]	_	_
17-8	3429-3443	protein-domain	abstract[176]|abstract[177]	new[176]|giv[177]	_	_
17-9	3444-3452	networks	abstract[176]|abstract[177]	new[176]|giv[177]	_	_
17-10	3453-3458	could	_	_	_	_
17-11	3459-3461	be	_	_	_	_
17-12	3462-3472	identified	_	_	_	_
17-13	3473-3480	through	_	_	_	_
17-14	3481-3483	in	_	_	_	_
17-15	3484-3489	vitro	_	_	_	_
17-16	3490-3492	or	_	_	_	_
17-17	3493-3495	in	_	_	_	_
17-18	3496-3500	vivo	abstract[178]	new[178]	_	_
17-19	3501-3509	targeted	abstract[178]	new[178]	_	_
17-20	3510-3519	evolution	abstract[178]	new[178]	_	_
17-21	3520-3522	of	abstract[178]	new[178]	_	_
17-22	3523-3541	EBU/SLiM-harboring	abstract[178]|event	new[178]|new	_	_
17-23	3542-3547	phage	abstract[178]	new[178]	_	_
17-24	3548-3557	displayed	_	_	_	_
17-25	3558-3565	peptide	object|place[181]	giv|giv[181]	_	_
17-26	3566-3575	libraries	place[181]	giv[181]	_	_
17-27	3576-3580	such	place[181]	giv[181]	_	_
17-28	3581-3583	as	place[181]	giv[181]	_	_
17-29	3584-3587	the	place[181]|abstract[184]	giv[181]|giv[184]	_	_
17-30	3588-3599	multivalent	place[181]|abstract[184]	giv[181]|giv[184]	_	_
17-31	3600-3609	landscape	place[181]|abstract|abstract[184]	giv[181]|giv|giv[184]	_	_
17-32	3610-3615	phage	place[181]|place|abstract[184]	giv[181]|giv|giv[184]	_	_
17-33	3616-3623	library	place[181]|abstract[184]	giv[181]|giv[184]	_	_
17-34	3624-3628	used	_	_	_	_
17-35	3629-3631	in	_	_	_	_
17-36	3632-3636	this	abstract[185]	new[185]	_	_
17-37	3637-3644	project	abstract[185]	new[185]	_	_
17-38	3645-3646	.	_	_	_	_

#Text=In accordance with this hypothesis , we identified the following three major types of EBU motifs : ( 1 ) motifs common for all tissues ; ( 2 ) motifs specific for organs with functionally related tissues and similar correlated patterns of co-expressed genes ; and ( 3 ) motifs unique to single tissues with unique functions , which may be related to tissue-specific gene expression profiles within the tissues or to specific physical features of the local microenvironment .
18-1	3647-3649	In	_	_	_	_
18-2	3650-3660	accordance	_	_	_	_
18-3	3661-3665	with	_	_	_	_
18-4	3666-3670	this	abstract[186]	giv[186]	_	_
18-5	3671-3681	hypothesis	abstract[186]	giv[186]	_	_
18-6	3682-3683	,	_	_	_	_
18-7	3684-3686	we	person	giv	ana	19-3
18-8	3687-3697	identified	_	_	_	_
18-9	3698-3701	the	place[188]|abstract[189]	new[188]|new[189]	coref|coref|coref|coref	19-15[212_188]|26-7[245_189]|19-15[212_188]|26-7[245_189]
18-10	3702-3711	following	place[188]|abstract[189]	new[188]|new[189]	_	_
18-11	3712-3717	three	place[188]|abstract[189]	new[188]|new[189]	_	_
18-12	3718-3723	major	place[188]|abstract[189]	new[188]|new[189]	_	_
18-13	3724-3729	types	place[188]|abstract[189]	new[188]|new[189]	_	_
18-14	3730-3732	of	place[188]|abstract[189]	new[188]|new[189]	_	_
18-15	3733-3736	EBU	place[188]|abstract[189]|abstract|abstract[191]	new[188]|new[189]|new|giv[191]	coref|coref	18-18[192_191]|18-18[192_191]
18-16	3737-3743	motifs	place[188]|abstract[189]|abstract[191]	new[188]|new[189]|giv[191]	_	_
18-17	3744-3745	:	abstract[189]	new[189]	_	_
18-18	3746-3747	(	abstract[189]|abstract[192]	new[189]|giv[192]	coref	18-30[194_192]
18-19	3748-3749	1	abstract[189]|abstract[192]	new[189]|giv[192]	_	_
18-20	3750-3751	)	abstract[189]|abstract[192]	new[189]|giv[192]	_	_
18-21	3752-3758	motifs	abstract[189]|abstract[192]	new[189]|giv[192]	_	_
18-22	3759-3765	common	abstract[189]|abstract[192]	new[189]|giv[192]	_	_
18-23	3766-3769	for	_	_	_	_
18-24	3770-3773	all	abstract[193]	giv[193]	coref	18-35[196_193]
18-25	3774-3781	tissues	abstract[193]	giv[193]	_	_
18-26	3782-3783	;	abstract[193]	giv[193]	_	_
18-27	3784-3785	(	abstract[193]	giv[193]	_	_
18-28	3786-3787	2	abstract[193]	giv[193]	_	_
18-29	3788-3789	)	abstract[193]	giv[193]	_	_
18-30	3790-3796	motifs	abstract[193]|abstract[194]	giv[193]|giv[194]	coref	18-47[199_194]
18-31	3797-3805	specific	abstract[193]|abstract[194]	giv[193]|giv[194]	_	_
18-32	3806-3809	for	_	_	_	_
18-33	3810-3816	organs	object[195]	new[195]	coref	26-1[242_195]
18-34	3817-3821	with	object[195]	new[195]	_	_
18-35	3822-3834	functionally	object[195]|abstract[196]	new[195]|giv[196]	coref	18-53[200_196]
18-36	3835-3842	related	object[195]|abstract[196]	new[195]|giv[196]	_	_
18-37	3843-3850	tissues	object[195]|abstract[196]	new[195]|giv[196]	_	_
18-38	3851-3854	and	object[195]|abstract[196]	new[195]|giv[196]	_	_
18-39	3855-3862	similar	object[195]|abstract[196]|abstract[197]	new[195]|giv[196]|new[197]	_	_
18-40	3863-3873	correlated	object[195]|abstract[196]|abstract[197]	new[195]|giv[196]|new[197]	_	_
18-41	3874-3882	patterns	object[195]|abstract[196]|abstract[197]	new[195]|giv[196]|new[197]	_	_
18-42	3883-3885	of	object[195]|abstract[196]|abstract[197]	new[195]|giv[196]|new[197]	_	_
18-43	3886-3898	co-expressed	object[195]|abstract[196]|abstract[197]|abstract[198]	new[195]|giv[196]|new[197]|new[198]	coref	21-19[0_198]
18-44	3899-3904	genes	object[195]|abstract[196]|abstract[197]|abstract[198]	new[195]|giv[196]|new[197]|new[198]	_	_
18-45	3905-3906	;	object[195]|abstract[196]|abstract[197]	new[195]|giv[196]|new[197]	_	_
18-46	3907-3910	and	object[195]|abstract[196]|abstract[197]	new[195]|giv[196]|new[197]	_	_
18-47	3911-3912	(	object[195]|abstract[196]|abstract[197]|abstract[199]	new[195]|giv[196]|new[197]|giv[199]	coref	19-9[210_199]
18-48	3913-3914	3	object[195]|abstract[196]|abstract[197]|abstract[199]	new[195]|giv[196]|new[197]|giv[199]	_	_
18-49	3915-3916	)	object[195]|abstract[196]|abstract[197]|abstract[199]	new[195]|giv[196]|new[197]|giv[199]	_	_
18-50	3917-3923	motifs	object[195]|abstract[196]|abstract[197]|abstract[199]	new[195]|giv[196]|new[197]|giv[199]	_	_
18-51	3924-3930	unique	object[195]|abstract[196]|abstract[197]|abstract[199]	new[195]|giv[196]|new[197]|giv[199]	_	_
18-52	3931-3933	to	_	_	_	_
18-53	3934-3940	single	abstract[200]	giv[200]	coref	18-69[205_200]
18-54	3941-3948	tissues	abstract[200]	giv[200]	_	_
18-55	3949-3953	with	abstract[200]	giv[200]	_	_
18-56	3954-3960	unique	abstract[200]|abstract[201]	giv[200]|new[201]	coref	26-17[248_201]
18-57	3961-3970	functions	abstract[200]|abstract[201]	giv[200]|new[201]	_	_
18-58	3971-3972	,	_	_	_	_
18-59	3973-3978	which	_	_	_	_
18-60	3979-3982	may	_	_	_	_
18-61	3983-3985	be	_	_	_	_
18-62	3986-3993	related	_	_	_	_
18-63	3994-3996	to	_	_	_	_
18-64	3997-4012	tissue-specific	object[204]	giv[204]	_	_
18-65	4013-4017	gene	abstract|object[204]	giv|giv[204]	coref	22-15
18-66	4018-4028	expression	abstract|object[204]	giv|giv[204]	coref	22-16
18-67	4029-4037	profiles	object[204]	giv[204]	_	_
18-68	4038-4044	within	object[204]	giv[204]	_	_
18-69	4045-4048	the	object[204]|abstract[205]	giv[204]|giv[205]	coref	22-10[228_205]
18-70	4049-4056	tissues	object[204]|abstract[205]	giv[204]|giv[205]	_	_
18-71	4057-4059	or	_	_	_	_
18-72	4060-4062	to	_	_	_	_
18-73	4063-4071	specific	abstract[206]	giv[206]	_	_
18-74	4072-4080	physical	abstract[206]	giv[206]	_	_
18-75	4081-4089	features	abstract[206]	giv[206]	_	_
18-76	4090-4092	of	abstract[206]	giv[206]	_	_
18-77	4093-4096	the	abstract[206]|abstract[207]	giv[206]|giv[207]	coref	26-12[247_207]
18-78	4097-4102	local	abstract[206]|abstract[207]	giv[206]|giv[207]	_	_
18-79	4103-4119	microenvironment	abstract[206]|abstract[207]	giv[206]|giv[207]	_	_
18-80	4120-4121	.	_	_	_	_

#Text=Here , we demonstrated that the frequencies of several 3-mer motifs are shared across all tissue types (
19-1	4122-4126	Here	_	_	_	_
19-2	4127-4128	,	_	_	_	_
19-3	4129-4131	we	person	giv	ana	27-3
19-4	4132-4144	demonstrated	_	_	_	_
19-5	4145-4149	that	_	_	_	_
19-6	4150-4153	the	abstract[209]	new[209]	_	_
19-7	4154-4165	frequencies	abstract[209]	new[209]	_	_
19-8	4166-4168	of	abstract[209]	new[209]	_	_
19-9	4169-4176	several	abstract[209]|abstract[210]	new[209]|giv[210]	coref	23-8[235_210]
19-10	4177-4182	3-mer	abstract[209]|abstract[210]	new[209]|giv[210]	_	_
19-11	4183-4189	motifs	abstract[209]|abstract[210]	new[209]|giv[210]	_	_
19-12	4190-4193	are	_	_	_	_
19-13	4194-4200	shared	_	_	_	_
19-14	4201-4207	across	_	_	_	_
19-15	4208-4211	all	place[212]	giv[212]	coref	21-25[222_212]
19-16	4212-4218	tissue	object|place[212]	giv|giv[212]	coref	21-26
19-17	4219-4224	types	place[212]	giv[212]	_	_
19-18	4225-4226	(	_	_	_	_

#Text=Figure 5
20-1	4227-4233	Figure	abstract[213]	new[213]	coref	24-1[241_213]
20-2	4234-4235	5	abstract[213]	new[213]	_	_

#Text=A , black arrow ) and can be representative of interactions with protein products of “ housekeeping-like ” genes expressed at constant levels across all tissue types , such as those involved in metabolism .
21-1	4236-4237	A	object[214]	new[214]	_	_
21-2	4238-4239	,	object[214]	new[214]	_	_
21-3	4240-4245	black	object[214]	new[214]	_	_
21-4	4246-4251	arrow	object[214]	new[214]	_	_
21-5	4252-4253	)	_	_	_	_
21-6	4254-4257	and	_	_	_	_
21-7	4258-4261	can	_	_	_	_
21-8	4262-4264	be	_	_	_	_
21-9	4265-4279	representative	_	_	_	_
21-10	4280-4282	of	_	_	_	_
21-11	4283-4295	interactions	abstract[215]	giv[215]	_	_
21-12	4296-4300	with	abstract[215]	giv[215]	_	_
21-13	4301-4308	protein	abstract[215]|substance|abstract[217]	giv[215]|new|new[217]	_	_
21-14	4309-4317	products	abstract[215]|abstract[217]	giv[215]|new[217]	_	_
21-15	4318-4320	of	abstract[215]|abstract[217]	giv[215]|new[217]	_	_
21-16	4321-4322	“	abstract[215]|abstract[217]	giv[215]|new[217]	_	_
21-17	4323-4340	housekeeping-like	abstract[215]|abstract[217]|abstract	giv[215]|new[217]|new	_	_
21-18	4341-4342	”	abstract[215]|abstract[217]	giv[215]|new[217]	_	_
21-19	4343-4348	genes	abstract[215]|abstract[217]|abstract	giv[215]|new[217]|giv	ana	21-31
21-20	4349-4358	expressed	_	_	_	_
21-21	4359-4361	at	_	_	_	_
21-22	4362-4370	constant	abstract[220]	new[220]	_	_
21-23	4371-4377	levels	abstract[220]	new[220]	_	_
21-24	4378-4384	across	abstract[220]	new[220]	_	_
21-25	4385-4388	all	abstract[220]|place[222]	new[220]|giv[222]	coref	26-7[244_222]
21-26	4389-4395	tissue	abstract[220]|object|place[222]	new[220]|giv|giv[222]	_	_
21-27	4396-4401	types	abstract[220]|place[222]	new[220]|giv[222]	_	_
21-28	4402-4403	,	abstract[220]	new[220]	_	_
21-29	4404-4408	such	abstract[220]	new[220]	_	_
21-30	4409-4411	as	abstract[220]	new[220]	_	_
21-31	4412-4417	those	abstract[220]|abstract	new[220]|giv	coref	27-20[257_0]
21-32	4418-4426	involved	_	_	_	_
21-33	4427-4429	in	_	_	_	_
21-34	4430-4440	metabolism	abstract	new	_	_
21-35	4441-4442	.	_	_	_	_

#Text=Similar patterns of motif enrichment could be identified in tissues with functionally-related roles and gene expression patterns .
22-1	4443-4450	Similar	abstract[225]	new[225]	coref	22-15[232_225]
22-2	4451-4459	patterns	abstract[225]	new[225]	_	_
22-3	4460-4462	of	abstract[225]	new[225]	_	_
22-4	4463-4468	motif	abstract[225]|abstract|abstract[227]	new[225]|new|new[227]	ana|coref|ana|coref	23-1[0_227]|27-5|23-1[0_227]|27-5
22-5	4469-4479	enrichment	abstract[225]|abstract[227]	new[225]|new[227]	_	_
22-6	4480-4485	could	_	_	_	_
22-7	4486-4488	be	_	_	_	_
22-8	4489-4499	identified	_	_	_	_
22-9	4500-4502	in	_	_	_	_
22-10	4503-4510	tissues	abstract[228]	giv[228]	coref	23-24[240_228]
22-11	4511-4515	with	abstract[228]	giv[228]	_	_
22-12	4516-4536	functionally-related	abstract[228]|abstract[229]	giv[228]|new[229]	_	_
22-13	4537-4542	roles	abstract[228]|abstract[229]	giv[228]|new[229]	_	_
22-14	4543-4546	and	abstract[228]	giv[228]	_	_
22-15	4547-4551	gene	abstract[228]|abstract|abstract[232]	giv[228]|giv|giv[232]	coref|coref	23-10[236_232]|23-10[236_232]
22-16	4552-4562	expression	abstract[228]|abstract|abstract[232]	giv[228]|giv|giv[232]	_	_
22-17	4563-4571	patterns	abstract[228]|abstract[232]	giv[228]|giv[232]	_	_
22-18	4572-4573	.	_	_	_	_

#Text=This can be visualized by enrichment of similar motifs patterns between the liver and spleen with 25 significantly enriched motifs being shared between both tissues (
23-1	4574-4578	This	abstract	giv	coref	23-6[234_0]
23-2	4579-4582	can	_	_	_	_
23-3	4583-4585	be	_	_	_	_
23-4	4586-4596	visualized	_	_	_	_
23-5	4597-4599	by	_	_	_	_
23-6	4600-4610	enrichment	abstract[234]	giv[234]	coref	27-5[253_234]
23-7	4611-4613	of	abstract[234]	giv[234]	_	_
23-8	4614-4621	similar	abstract[234]|abstract[235]	giv[234]|giv[235]	coref	23-17[239_235]
23-9	4622-4628	motifs	abstract[234]|abstract[235]	giv[234]|giv[235]	_	_
23-10	4629-4637	patterns	abstract[234]|abstract[236]	giv[234]|giv[236]	_	_
23-11	4638-4645	between	abstract[234]|abstract[236]	giv[234]|giv[236]	_	_
23-12	4646-4649	the	abstract[234]|abstract[236]|object[237]	giv[234]|giv[236]|new[237]	_	_
23-13	4650-4655	liver	abstract[234]|abstract[236]|object[237]	giv[234]|giv[236]|new[237]	_	_
23-14	4656-4659	and	abstract[234]|abstract[236]	giv[234]|giv[236]	_	_
23-15	4660-4666	spleen	abstract[234]|abstract[236]|object	giv[234]|giv[236]|new	_	_
23-16	4667-4671	with	_	_	_	_
23-17	4672-4674	25	abstract[239]	giv[239]	coref	28-5[263_239]
23-18	4675-4688	significantly	abstract[239]	giv[239]	_	_
23-19	4689-4697	enriched	abstract[239]	giv[239]	_	_
23-20	4698-4704	motifs	abstract[239]	giv[239]	_	_
23-21	4705-4710	being	_	_	_	_
23-22	4711-4717	shared	_	_	_	_
23-23	4718-4725	between	_	_	_	_
23-24	4726-4730	both	abstract[240]	giv[240]	coref	27-8[254_240]
23-25	4731-4738	tissues	abstract[240]	giv[240]	_	_
23-26	4739-4740	(	_	_	_	_

#Text=Figure 5
24-1	4741-4747	Figure	abstract[241]	giv[241]	_	_
24-2	4748-4749	5	abstract[241]	giv[241]	_	_

#Text=A ) .
25-1	4750-4751	A	_	_	_	_
25-2	4752-4753	)	_	_	_	_
25-3	4754-4755	.	_	_	_	_

#Text=These organs are expected to contain cell types or structures within the local microenvironment that have common biological functions , representing a theoretical construct for targeting to a multi-organ system .
26-1	4756-4761	These	object[242]	giv[242]	_	_
26-2	4762-4768	organs	object[242]	giv[242]	_	_
26-3	4769-4772	are	_	_	_	_
26-4	4773-4781	expected	_	_	_	_
26-5	4782-4784	to	_	_	_	_
26-6	4785-4792	contain	_	_	_	_
26-7	4793-4797	cell	object|place[244]|abstract[245]	new|giv[244]|giv[245]	_	_
26-8	4798-4803	types	place[244]|abstract[245]	giv[244]|giv[245]	_	_
26-9	4804-4806	or	abstract[245]	giv[245]	_	_
26-10	4807-4817	structures	abstract[245]|abstract	giv[245]|new	coref	27-26
26-11	4818-4824	within	_	_	_	_
26-12	4825-4828	the	abstract[247]	giv[247]	coref	27-28[259_247]
26-13	4829-4834	local	abstract[247]	giv[247]	_	_
26-14	4835-4851	microenvironment	abstract[247]	giv[247]	_	_
26-15	4852-4856	that	_	_	_	_
26-16	4857-4861	have	_	_	_	_
26-17	4862-4868	common	abstract[248]	giv[248]	_	_
26-18	4869-4879	biological	abstract[248]	giv[248]	_	_
26-19	4880-4889	functions	abstract[248]	giv[248]	_	_
26-20	4890-4891	,	_	_	_	_
26-21	4892-4904	representing	_	_	_	_
26-22	4905-4906	a	abstract[249]	new[249]	_	_
26-23	4907-4918	theoretical	abstract[249]	new[249]	_	_
26-24	4919-4928	construct	abstract[249]	new[249]	_	_
26-25	4929-4932	for	_	_	_	_
26-26	4933-4942	targeting	_	_	_	_
26-27	4943-4945	to	_	_	_	_
26-28	4946-4947	a	abstract[250]	new[250]	_	_
26-29	4948-4959	multi-organ	abstract[250]	new[250]	_	_
26-30	4960-4966	system	abstract[250]	new[250]	_	_
26-31	4967-4968	.	_	_	_	_

#Text=Finally , we demonstrated motif enrichment within single tissues , including the tumor xenograft , which suggests there are tissue-specific genes that are overexpressed or structures in the microenvironment that allow for tissue-selective accumulation of phages .
27-1	4969-4976	Finally	_	_	_	_
27-2	4977-4978	,	_	_	_	_
27-3	4979-4981	we	person	giv	_	_
27-4	4982-4994	demonstrated	_	_	_	_
27-5	4995-5000	motif	abstract|abstract[253]	giv|giv[253]	_	_
27-6	5001-5011	enrichment	abstract[253]	giv[253]	_	_
27-7	5012-5018	within	_	_	_	_
27-8	5019-5025	single	abstract[254]	giv[254]	_	_
27-9	5026-5033	tissues	abstract[254]	giv[254]	_	_
27-10	5034-5035	,	abstract[254]	giv[254]	_	_
27-11	5036-5045	including	abstract[254]	giv[254]	_	_
27-12	5046-5049	the	abstract[254]|object[256]	giv[254]|new[256]	_	_
27-13	5050-5055	tumor	abstract[254]|abstract|object[256]	giv[254]|new|new[256]	coref	28-17
27-14	5056-5065	xenograft	abstract[254]|object[256]	giv[254]|new[256]	_	_
27-15	5066-5067	,	_	_	_	_
27-16	5068-5073	which	_	_	_	_
27-17	5074-5082	suggests	_	_	_	_
27-18	5083-5088	there	_	_	_	_
27-19	5089-5092	are	_	_	_	_
27-20	5093-5108	tissue-specific	abstract[257]	giv[257]	_	_
27-21	5109-5114	genes	abstract[257]	giv[257]	_	_
27-22	5115-5119	that	_	_	_	_
27-23	5120-5123	are	_	_	_	_
27-24	5124-5137	overexpressed	_	_	_	_
27-25	5138-5140	or	_	_	_	_
27-26	5141-5151	structures	abstract	giv	_	_
27-27	5152-5154	in	_	_	_	_
27-28	5155-5158	the	abstract[259]	giv[259]	coref	28-16[266_259]
27-29	5159-5175	microenvironment	abstract[259]	giv[259]	_	_
27-30	5176-5180	that	_	_	_	_
27-31	5181-5186	allow	_	_	_	_
27-32	5187-5190	for	_	_	_	_
27-33	5191-5207	tissue-selective	abstract[260]	giv[260]	ana	28-1[0_260]
27-34	5208-5220	accumulation	abstract[260]	giv[260]	_	_
27-35	5221-5223	of	abstract[260]	giv[260]	_	_
27-36	5224-5230	phages	abstract[260]|abstract	giv[260]|giv	_	_
27-37	5231-5232	.	_	_	_	_

#Text=This is demonstrated by 3-mer motifs like “ MYW ” that are only enriched within the tumor microenvironment and suggested to play a role in selective binding of a tumor-specific marker .
28-1	5233-5237	This	abstract	giv	_	_
28-2	5238-5240	is	_	_	_	_
28-3	5241-5253	demonstrated	_	_	_	_
28-4	5254-5256	by	_	_	_	_
28-5	5257-5262	3-mer	abstract[263]	giv[263]	_	_
28-6	5263-5269	motifs	abstract[263]	giv[263]	_	_
28-7	5270-5274	like	abstract[263]	giv[263]	_	_
28-8	5275-5276	“	abstract[263]	giv[263]	_	_
28-9	5277-5280	MYW	abstract[263]|abstract	giv[263]|new	_	_
28-10	5281-5282	”	abstract[263]	giv[263]	_	_
28-11	5283-5287	that	_	_	_	_
28-12	5288-5291	are	_	_	_	_
28-13	5292-5296	only	_	_	_	_
28-14	5297-5305	enriched	_	_	_	_
28-15	5306-5312	within	_	_	_	_
28-16	5313-5316	the	abstract[266]	giv[266]	_	_
28-17	5317-5322	tumor	abstract|abstract[266]	giv|giv[266]	_	_
28-18	5323-5339	microenvironment	abstract[266]	giv[266]	_	_
28-19	5340-5343	and	_	_	_	_
28-20	5344-5353	suggested	_	_	_	_
28-21	5354-5356	to	_	_	_	_
28-22	5357-5361	play	_	_	_	_
28-23	5362-5363	a	abstract[267]	new[267]	_	_
28-24	5364-5368	role	abstract[267]	new[267]	_	_
28-25	5369-5371	in	abstract[267]	new[267]	_	_
28-26	5372-5381	selective	abstract[267]|abstract[268]	new[267]|new[268]	_	_
28-27	5382-5389	binding	abstract[267]|abstract[268]	new[267]|new[268]	_	_
28-28	5390-5392	of	abstract[267]|abstract[268]	new[267]|new[268]	_	_
28-29	5393-5394	a	abstract[267]|abstract[268]|abstract[269]	new[267]|new[268]|new[269]	_	_
28-30	5395-5409	tumor-specific	abstract[267]|abstract[268]|abstract[269]	new[267]|new[268]|new[269]	_	_
28-31	5410-5416	marker	abstract[267]|abstract[268]|abstract[269]	new[267]|new[268]|new[269]	_	_
28-32	5417-5418	.	_	_	_	_
